FOLH1 and neoplasm: PSMA PET has been shown to have comparable sensitivity and specificity as 18F-NaF PET for bone metastases in one study [21], however Uprimny et al. [22] found 18F-NaF PET detected more skeletal metastases and had a higher tumour to background ratio than PSMA PET.